Overview

Corneal Crosslinking Treatment Study

Status:
Recruiting

Trial end date:
2022-03-01

Target enrollment:

Participant gender:

Summary

Three different protocols for inducing corneal crosslinks in subjets with progressive keratoconus will be evaluated in this randomised clinical study.

Phase:

Phase 4

Details

Lead Sponsor:

Region Skane

Treatments:

Riboflavin